Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

febuprol

Known as: 3-butoxy-1-phenoxy-propanol-(2) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE:To develop a HPLC method for the determination of the principal agent in febuprol pills.METHODS:The principal agent was… Expand
1991
1991
  • Li Rui
  • 1991
  • Corpus ID: 204578060
 
1988
1988
The effect of a new potent choleretic drug (Febuprol) on lipid composition and cholesterol nucleation time in gallbladder bile… Expand
1987
1987
10 patients with right upper quadrant pain were treated with a choleretic agent (Febuprol; 3 X 200 mg t. i. d.) and placebo in a… Expand
1983
1983
In a clinical trial, performed according to new criteria of the AMG (Arzneimittelgesetz) 1976, a new choleretic monosubstance 3-n… Expand
1978
1978
In previous pharmacological experiments with the choleretic agent Febuprol, healthy subjects showed a significant increase in… Expand
1977
1977
The spasmolytic activity of 3-butoxy-1-phenoxy-propanol-(2) (febuprol) on the biliary tract is demonstrated in two different… Expand
1976
1976
The pharmacokinetic behaviour as well as metabolization of 3-butoxy - 1 - phenoxy-propanol-(2) (febuprol) in rats and mice were… Expand
1976
1976
The choleretic effect of 3-butoxy-1-phenoxypropanol-(2), Febuprol (INN), was examined in healthy volunteer subjects. In a dose… Expand